Long-Term Clinical Outcomes of Iliac Artery Endovascular Therapy in the Korean Vascular Intervention Society Endovascular Therapy in Lower Limb Artery Diseases (K-VIS ELLA) Registry

다국어 초록 (Multilingual Abstract)

Background and Objectives: Limited data are available regarding long-term clinical outcomes of iliac artery endovascular therapy (EVT) in real-world practice. This study investigated long-term outcomes according to Trans-Atlantic Inter-Society Consensus (TASC) classifications.
Methods: We analyzed data from 1,705 limbs of 1,364 patients from the retrospective cohort of the multicenter Korean Vascular Intervention Society Endovascular Therapy in Lower Limb Artery Disease registry. The primary endpoint was target lesion revascularization (TLR)-free survival.
Results: TASC A, B, C, and D lesions were present in 19.4%, 26.2%, 28.7%, and 25.7% of the treated limbs, respectively. The technical success rate was 96.2% and did not differ between TASC lesion types. Complications occurred in 6.8% of cases and more occurred in TASC D (11.8%). Iliac artery EVT showed a 5-year TLR-free survival of 89.2%. The TASC D group had the lowest TLR-free rate of 79.3%. TASC D (hazard ratio [HR], 1.75; 95% confidence interval [CI], 1.12–2.73; p=0.014), plain old balloon angioplasty (HR, 4.25; 95% CI, 2.03–8.88; p<0.001), current smoker (HR, 1.89; 95% CI, 1.26–2.83; p=0.002), previous bypass surgery (HR, 3.04; 95% CI, 1.28–7.19; p=0.011), combined femoropopliteal treatment (HR, 4.89; 95% CI, 3.19–7.50; p<0.001), combined below the knee treatment (HR, 2.20; 95% CI, 1.25–3.89; p=0.007), and complications (HR, 1.86; 95% CI, 1.07–3.24; p=0.028) were predictors for TLR.
Conclusions: Iliac artery EVT achieved excellent technical success and 5-year TLR-free survival. TASC D showed a favorable but lower 5-year TLR-free survival rate and higher complication rate compared with other TASC groups.

참고문헌 (Reference)

1 Bechter-Hugl B, "The influence of gender on patency rates after iliac artery stenting" 59 : 1588-1596, 2014

2 Society for Vascular Surgery Lower Extremity Guidelines Writing Group, "Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities : management of asymptomatic disease and claudication" 61 : 2-, 2015

3 Piffaretti G, "Outcomes from the multicenter italian registry on primary endovascular treatment of aortoiliac occlusive disease" 26 : 623-632, 2019

4 Çakmak EÖ, "Midterm outcomes on primary endovascular treatment of 395aortoiliac occlusive disease patients : a single-center experience" 72 : 640-650, 2021

5 Premaratne S, "Meta-analysis of direct surgical versus endovascular revascularization for aortoiliac occlusive disease" 72 : 726-737, 2020

6 Criqui MH, "Lower extremity peripheral artery disease : contemporary epidemiology, management gaps, and future directions : a scientific statement from the American Heart Association" 144 : e171-91, 2021

7 Dae-Young Kim ; Young-Guk Ko ; Seung-Jun Lee ; Chul-Min Ahn ; Seung-Woon Rha ; Cheol Ung Choi ; Jong Kwan Park ; Chang-Hwan Yoon ; Seung-Hyuk Choi ; Pil-Ki Min ; Jang-Whan Bae ; Jung-Kyu Han ; Sang Ho Park ; 최동훈, "Korean Multicenter Registry Study of EPIC Stents for the Treatment of Iliac Artery Disease: K-EPIC Registry" 대한심장학회 51 (51): 441-451, 2021

8 Norgren L, "Inter-society consensus for the management of peripheral arterial disease(TASC II)" 45 (45): S5-S67, 2007

9 Psacharopulo D, "Increasing efficacy of endovascular recanalization with covered stent graft for TransAtlantic Inter-Society Consensus II D aortoiliac complex occlusion" 62 : 1219-1226, 2015

10 Suzuki K, "Efficacy and safety of endovascular therapy for aortoiliac TASC D lesions" 68 : 67-73, 2017

11 Ye W, "Early and late outcomes of percutaneous treatment of TransAtlantic Inter-Society Consensus class C and D aorto-iliac lesions" 53 : 1728-1737, 2011

12 European Stroke Organisation, "ESC Guidelines on the diagnosis and treatment of peripheral artery diseases : document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries : the task force on the diagnosis and treatment of peripheral artery diseases of the European Society of Cardiology(ESC)" 32 : 2851-2906, 2011

13 Indes JE, "Clinical outcomes of 5358 patients undergoing direct open bypass or endovascular treatment for aortoiliac occlusive disease : a systematic review and meta-analysis" 20 : 443-455, 2013

14 Rossi M, "Cardiovascular and Interventional Radiological Society of Europe guidelines on endovascular treatment in aortoiliac arterial disease" 37 : 13-25, 2014

15 고영국 ; 안철민 ; 민필기 ; 이재환 ; 윤창환 ; 유철웅 ; 이승환 ; 이상록 ; 최승혁 ; 고윤석 ; 채인호 ; 최동훈 ; K-VIS investigators, "Baseline Characteristics of a Retrospective Patient Cohort in the Korean Vascular Intervention Society Endovascular Therapy in Lower Limb Artery Diseases (K-VIS ELLA) Registry" 대한심장학회 47 (47): 469-476, 2017

16 Jongkind V, "A systematic review of endovascular treatment of extensive aortoiliac occlusive disease" 52 : 1376-1383, 2010

17 de Donato G, "24-month data from the BRAVISSIMO : a large-scale prospective registry on iliac stenting for TASC A & B and TASC C & D lesions" 29 : 738-750, 2015

18 Aboyans V, "2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery(ESVS) : document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by : the European Stroke Organization(ESO). The task force for the diagnosis and treatment of peripheral arterial diseases of the European Society of Cardiology(ESC)and of the European Society for Vascular Surgery(ESVS)" 39 : 763-816, 2018

19 Gerhard-Herman MD, "2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease : a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines" 69 : e71-126, 2017